1. Home
  2. LZM vs ALMS Comparison

LZM vs ALMS Comparison

Compare LZM & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LZM
  • ALMS
  • Stock Information
  • Founded
  • LZM 2021
  • ALMS 2021
  • Country
  • LZM Isle of Man
  • ALMS United States
  • Employees
  • LZM N/A
  • ALMS N/A
  • Industry
  • LZM Metal Mining
  • ALMS
  • Sector
  • LZM Basic Materials
  • ALMS
  • Exchange
  • LZM Nasdaq
  • ALMS NYSE
  • Market Cap
  • LZM 348.9M
  • ALMS 402.6M
  • IPO Year
  • LZM N/A
  • ALMS 2024
  • Fundamental
  • Price
  • LZM $4.20
  • ALMS $4.13
  • Analyst Decision
  • LZM Strong Buy
  • ALMS Strong Buy
  • Analyst Count
  • LZM 1
  • ALMS 6
  • Target Price
  • LZM $14.00
  • ALMS $19.80
  • AVG Volume (30 Days)
  • LZM 111.2K
  • ALMS 678.8K
  • Earning Date
  • LZM 08-18-2025
  • ALMS 08-12-2025
  • Dividend Yield
  • LZM N/A
  • ALMS N/A
  • EPS Growth
  • LZM N/A
  • ALMS N/A
  • EPS
  • LZM N/A
  • ALMS N/A
  • Revenue
  • LZM $140,522.00
  • ALMS $17,389,000.00
  • Revenue This Year
  • LZM $611.56
  • ALMS N/A
  • Revenue Next Year
  • LZM $344.44
  • ALMS N/A
  • P/E Ratio
  • LZM N/A
  • ALMS N/A
  • Revenue Growth
  • LZM N/A
  • ALMS N/A
  • 52 Week Low
  • LZM $2.90
  • ALMS $2.76
  • 52 Week High
  • LZM $7.94
  • ALMS $13.11
  • Technical
  • Relative Strength Index (RSI)
  • LZM 44.05
  • ALMS N/A
  • Support Level
  • LZM $4.21
  • ALMS N/A
  • Resistance Level
  • LZM $4.89
  • ALMS N/A
  • Average True Range (ATR)
  • LZM 0.31
  • ALMS 0.00
  • MACD
  • LZM -0.05
  • ALMS 0.00
  • Stochastic Oscillator
  • LZM 27.27
  • ALMS 0.00

About LZM Lifezone Metals Limited

Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate.

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

Share on Social Networks: